Skip to content

STUDIO DISFRUTA

Active
Private limited companyfounded 20206 yrs activeLanglaarsteenweg 110, 2630 Aartselaar, BelgiumKBO/BCE: BE 0745.965.335
Summary

STUDIO DISFRUTA has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,811 and a net result of €9,478. Equity is growing by ~19.1% per year across the filed fiscal years. Its solvency ranks better than 21% of 12918 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Risk analysisWatch ReportCompare
STUDIO DISFRUTAActiveChecked score 68/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€1.1mtotal assets 2025
Equity
€30,811
Profit
€9,478
Turnover not published (abridged schema)
Financial health
68 Healthy Checked score 2025
Bankruptcy chance 12 m
0.8%
Structure
Accounts on time0 of 1 deed read
Why 68- Equity €30,811 (2.7% of total assets)- Founded in 2020- Sector Wholesale trade (NACE 46)+ Size: total assets €1.1mShow the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 50% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 28+1
equity 2.7% of total assets
Liquidity 53+2
short-term debt 8.8% · cash 2.5%
Profitability 47-6
return on assets 0.8%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,775 companies)
Last 24 months 11-2024: 2.6%highest value 12-2024: 0.8%▼ -69.2% vs 11-2024 01-2025: 0.8%● 0.0% vs 12-2024 02-2025: 0.8%● 0.0% vs 01-2025 03-2025: 0.8%● 0.0% vs 02-2025 04-2025: 0.8%▼ -2.2% vs 03-2025 05-2025: 0.8%▲ +1.6% vs 04-2025 06-2025: 0.8%● 0.0% vs 05-2025 07-2025: 0.8%▲ +4.2% vs 06-2025 08-2025: 0.9%▲ +7.2% vs 07-2025 09-2025: 1.0%▲ +11.4% vs 08-2025 10-2025: 1.0%▲ +2.8% vs 09-2025 11-2025: 1.4%▲ +43.6% vs 10-2025 12-2025: 0.6%▼ -61.4% vs 11-2025 01-2026: 0.6%● 0.0% vs 12-2025 02-2026: 0.6%● 0.0% vs 01-2026 03-2026: 0.6%● 0.0% vs 02-2026 04-2026: 0.6%▼ -0.2% vs 03-2026 05-2026: 0.6%▲ +1.6% vs 04-2026 06-2026: 0.6%▲ +6.9% vs 05-2026 07-2026: 0.6%▼ -8.6% vs 06-2026lowest value 08-2026: 0.6%▲ +10.2% vs 07-2026 09-2026: 0.7%▲ +15.5% vs 08-2026 10-2026: 0.8%▲ +15.3% vs 09-2026
  • Size: total assets €1.1m lowers the probability for this profile
  • Equity €30,811 (2.7% of total assets) raises the probability
  • Founded in 2020 raises the probability for this profile
  • Sector Wholesale trade (NACE 46) raises the probability
Credit up to €2,000 at 30 days acceptable
Liquidity short (current ratio 0.39 against 0.24 in 2024; short-term debt: 8.8% and cash: 2.5% of total assets), and 97.3% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 18%, liquidity 58%, profitability 37%, growth against the median 86%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €1.1m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · Equity €30,811 (2.7% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Founded in 2020
In the bankruptcy model this factor raises the probability for this profile.
KBO
raises risk · Sector Wholesale trade (NACE 46)
In the bankruptcy model this factor raises the probability.
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 12918 sector peers (2025).
NBB · sector comparison
Position among 12918 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
on the day
2024
30 d late
2023
23 d late
2022
3 d late
2021
85 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 28 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 23 November (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close03-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Back to profitnet €9,478
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Among the largest 7% on total assetssector median €172,824 · 12,928 companies €1.1m View
  • Total assets 20255 fiscal years filed €1.1m View
  • Active since 2020founded 14-04-2020 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.1m
Profit
€9,478
Solvency
2.7%
Total assets▼ 2.4%
Net result
20212025
Go to Financials

Timeline

Events
9
Since
2022
Next accounts
by 31-10-2026
  1. 31-10-2025Annual accounts filed
  2. 31-03-2025Back to profit
  3. 30-11-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
14-04-2020
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure